Nuffield Department of Surgical Sciences

JNDS: new issue published

22 March 2023

A new issue of Journal of the Nuffield Department of Surgical Sciences (JNDS) has just been published.

New Cochrane review on antihistamines for motion sickness

9 December 2022

A new systematic review from Cochrane ENT at the Nuffield Department of Surgical Sciences says antihistamines are likely to reduce the risk of developing motion sickness (travel sickness) in susceptible adults under naturally occurring conditions of movement, but they may be more likely to cause drowsiness than placebo.

Read the latest issue of JNDS

2 September 2022

A new issue of Journal of the Nuffield Department of Surgical Sciences (JNDS) is out now.

Genetic mapping of tumours reveals how cancers grow

11 August 2022

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

14 June 2022

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2 June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New reporting guidelines developed to improve AI in healthcare settings

19 May 2022

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Study finds higher risk of all-cause mortality among paediatric cancer patients in LMICs during the pandemic

13 April 2022

During the first nine months of the COVID-19 pandemic, paediatric cancer patients from lower- and middle-income countries (LMICs) faced a higher risk of all-cause mortality than those in high-income countries, according to an international study led by the University of Oxford.

Automated assessment of pathology image quality

6 April 2022

The new Oxford-developed artificial intelligence tool PathProfiler automates the quality control of large retrospective pathology image datasets to increase their usability in downstream research.

Study reveals that bone changes energy requirements of cancer cells to promote growth and survival

11 March 2022

Interrogating metabolic cross-talk in the tumour-bone microenvironment, new research from the Edwards Group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.

Special issue of JNDS published

24 November 2021

Journal of the Nuffield Department of Surgical Sciences (JNDS) has published a new special issue, featuring highlights from the 2021 NDS Virtual Research Away Day.

Discovered gene patterns can predict prostate cancer treatment response

17 September 2021

Nearly 40,000 men are diagnosed with prostate cancer each year in the UK. Perhaps the most significant clinical challenge today is deciding which type of treatment will work best for different patient groups.

Largest trial of carotid artery surgery and stenting finds similar long-term effects on stroke risk

30 August 2021

Results from a major clinical trial demonstrate that both stenting and surgery are low-risk and similarly effective procedures for treating carotid artery disease.

New issue of JNDS now online

16 August 2021

A new issue of the Journal of the Nuffield Department of Surgical Sciences (JNDS) has been published.

New Cochrane evidence highlights uncertainty about the interventions used to prevent and treat loss of smell after COVID-19 infection

3 August 2021

Cochrane ENT at the Nuffield Department of Surgical Sciences has published two systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell following COVID-19 infection.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

21 June 2021

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Artificial intelligence tool for streamlining pathology workflow

26 May 2021

A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

Search results

Found 50 matches for